401k Plan data: CANCER GENETICS, INC 401(K) P/S PLAN plan

CANCER GENETICS, INC 401(K) P/S PLAN 401k Plan overview

Plan Name	CANCER GENETICS, INC 401(K) P/S PLAN
Plan identification number	001

CANCER GENETICS, INC 401(K) P/S PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

CANCER GENETICS, INC has sponsored the creation of one or more 401k plans.

Company Name: CANCER GENETICS, INC

Employer identification number (EIN): 043462475

NAIC Classification: 541700

Form 5500 Filing Information

Submission information for form 5500 for 401k plan CANCER GENETICS, INC 401(K) P/S PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01 ANDREW DAVID CHAPMAN LAFRENCE 2023-06-22 ANDREW DAVID CHAPMAN LAFRENCE 2023-06-22
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 JOHN A ROBERTS
001 2016-01-01 IGOR GITELMAN
001 2015-01-01 EDWARD SITAR
001 2014-01-01 EDWARD SITAR 2015-06-15
001 2013-01-01 EDMUND CAVIASCO 2014-06-19
001 2012-01-01 ELIZABETH CZEREPAK 2013-06-18
001 2011-01-01 BEVERLY REED 2012-07-24
001 2010-01-01 CANCER GENETICS INC 2011-07-19

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01	ANDREW DAVID CHAPMAN LAFRENCE	2023-06-22	ANDREW DAVID CHAPMAN LAFRENCE	2023-06-22
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	JOHN A ROBERTS
001	2016-01-01	IGOR GITELMAN
001	2015-01-01	EDWARD SITAR
001	2014-01-01	EDWARD SITAR	2015-06-15
001	2013-01-01	EDMUND CAVIASCO	2014-06-19
001	2012-01-01	ELIZABETH CZEREPAK	2013-06-18
001	2011-01-01	BEVERLY REED	2012-07-24
001	2010-01-01	CANCER GENETICS INC	2011-07-19

Plan Statistics for CANCER GENETICS, INC 401(K) P/S PLAN

401k plan membership statisitcs for CANCER GENETICS, INC 401(K) P/S PLAN

Measure Date Value
2020: CANCER GENETICS, INC 401(K) P/S PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 152
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 0
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 0
Total of all active and inactive participants 2020-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 0
Number of participants with account balances 2020-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: CANCER GENETICS, INC 401(K) P/S PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 178
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 86
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 66
Total of all active and inactive participants 2019-01-01 152
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 152
Number of participants with account balances 2019-01-01 110
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: CANCER GENETICS, INC 401(K) P/S PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 212
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 111
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 72
Total of all active and inactive participants 2018-01-01 183
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 183
Number of participants with account balances 2018-01-01 122
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: CANCER GENETICS, INC 401(K) P/S PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 203
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 162
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 50
Total of all active and inactive participants 2017-01-01 212
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 212
Number of participants with account balances 2017-01-01 131
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: CANCER GENETICS, INC 401(K) P/S PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 223
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 135
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 45
Total of all active and inactive participants 2016-01-01 180
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 180
Number of participants with account balances 2016-01-01 125
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: CANCER GENETICS, INC 401(K) P/S PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 198
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 190
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 29
Total of all active and inactive participants 2015-01-01 219
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 219
Number of participants with account balances 2015-01-01 136
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0

Measure	Date	Value
2020: CANCER GENETICS, INC 401(K) P/S PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	152
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	0
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	0
Total of all active and inactive participants	2020-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	0
Number of participants with account balances	2020-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: CANCER GENETICS, INC 401(K) P/S PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	178
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	86
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	66
Total of all active and inactive participants	2019-01-01	152
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	152
Number of participants with account balances	2019-01-01	110
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: CANCER GENETICS, INC 401(K) P/S PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	212
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	111
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	72
Total of all active and inactive participants	2018-01-01	183
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	183
Number of participants with account balances	2018-01-01	122
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: CANCER GENETICS, INC 401(K) P/S PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	203
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	162
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	50
Total of all active and inactive participants	2017-01-01	212
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	212
Number of participants with account balances	2017-01-01	131
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: CANCER GENETICS, INC 401(K) P/S PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	223
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	135
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	45
Total of all active and inactive participants	2016-01-01	180
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	180
Number of participants with account balances	2016-01-01	125
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: CANCER GENETICS, INC 401(K) P/S PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	198
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	190
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	29
Total of all active and inactive participants	2015-01-01	219
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	219
Number of participants with account balances	2015-01-01	136
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0

Financial Data on CANCER GENETICS, INC 401(K) P/S PLAN

Measure	Date	Value
2020 : CANCER GENETICS, INC 401(K) P/S PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-06-01	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-06-01	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-06-01	$0
Total income from all sources (including contributions)	2020-06-01	$-213,299
Total loss/gain on sale of assets	2020-06-01	$0
Total of all expenses incurred	2020-06-01	$3,096,550
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-06-01	$3,076,229
Value of total corrective distributions	2020-06-01	$2,048
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-06-01	$957
Value of total assets at end of year	2020-06-01	$0
Value of total assets at beginning of year	2020-06-01	$3,309,849
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-06-01	$18,273
Total interest from all sources	2020-06-01	$214
Total dividends received (eg from common stock, registered investment company shares)	2020-06-01	$13,726
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-06-01	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2020-06-01	$0
Total dividends received from registered investment company shares (eg mutual funds)	2020-06-01	$13,726
Was this plan covered by a fidelity bond	2020-06-01	Yes
Value of fidelity bond cover	2020-06-01	$250,000
If this is an individual account plan, was there a blackout period	2020-06-01	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-06-01	$0
Were there any nonexempt tranactions with any party-in-interest	2020-06-01	No
Contributions received from participants	2020-06-01	$0
Participant contributions at end of year	2020-06-01	$0
Participant contributions at beginning of year	2020-06-01	$5,065
Participant contributions at end of year	2020-06-01	$0
Participant contributions at beginning of year	2020-06-01	$0
Income. Received or receivable in cash from other sources (including rollovers)	2020-06-01	$957
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-06-01	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-06-01	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-06-01	No
Value of net income/loss	2020-06-01	$-3,309,849
Value of net assets at end of year (total assets less liabilities)	2020-06-01	$0
Value of net assets at beginning of year (total assets less liabilities)	2020-06-01	$3,309,849
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-06-01	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-06-01	No
Were any leases to which the plan was party in default or uncollectible	2020-06-01	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-06-01	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-06-01	$3,304,767
Interest on participant loans	2020-06-01	$139
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-06-01	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-06-01	$17
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-06-01	$17
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-06-01	$75
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-06-01	$-228,196
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-06-01	No
Was there a failure to transmit to the plan any participant contributions	2020-06-01	No
Has the plan failed to provide any benefit when due under the plan	2020-06-01	No
Contributions received in cash from employer	2020-06-01	$0
Employer contributions (assets) at end of year	2020-06-01	$0
Employer contributions (assets) at beginning of year	2020-06-01	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-06-01	$3,076,229
Contract administrator fees	2020-06-01	$18,273
Did the plan have assets held for investment	2020-06-01	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-06-01	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-06-01	Yes
Opinion of an independent qualified public accountant for this plan	2020-06-01	Disclaimer
Accountancy firm name	2020-06-01	CHERRY BEKAERT LLP
Accountancy firm EIN	2020-06-01	560574444
2019 : CANCER GENETICS, INC 401(K) P/S PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$1,024,587
Total income from all sources (including contributions)	2019-12-31	$1,024,587
Total loss/gain on sale of assets	2019-12-31	$0
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$692,802
Total of all expenses incurred	2019-12-31	$692,802
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$672,796
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$672,796
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$424,669
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$424,669
Value of total assets at end of year	2019-12-31	$3,309,849
Value of total assets at end of year	2019-12-31	$3,309,849
Value of total assets at beginning of year	2019-12-31	$2,978,064
Value of total assets at beginning of year	2019-12-31	$2,978,064
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$20,006
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$20,006
Total interest from all sources	2019-12-31	$1,085
Total interest from all sources	2019-12-31	$1,085
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$71,257
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$71,257
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$71,257
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$71,257
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$250,000
Value of fidelity bond cover	2019-12-31	$250,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$424,343
Contributions received from participants	2019-12-31	$424,343
Participant contributions at end of year	2019-12-31	$5,065
Participant contributions at end of year	2019-12-31	$5,065
Participant contributions at beginning of year	2019-12-31	$26,250
Participant contributions at beginning of year	2019-12-31	$26,250
Participant contributions at end of year	2019-12-31	$0
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$326
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$326
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$331,785
Value of net income/loss	2019-12-31	$331,785
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$3,309,849
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$3,309,849
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$2,978,064
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$2,978,064
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$3,304,767
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$3,304,767
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$2,951,798
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$2,951,798
Interest on participant loans	2019-12-31	$971
Interest on participant loans	2019-12-31	$971
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$17
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$17
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$16
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$16
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$16
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$16
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$114
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$114
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$527,576
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$527,576
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$0
Contributions received in cash from employer	2019-12-31	$0
Employer contributions (assets) at end of year	2019-12-31	$0
Employer contributions (assets) at end of year	2019-12-31	$0
Employer contributions (assets) at beginning of year	2019-12-31	$0
Employer contributions (assets) at beginning of year	2019-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$672,796
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$672,796
Contract administrator fees	2019-12-31	$20,006
Contract administrator fees	2019-12-31	$20,006
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	CHERRY BEKAERT LLP
Accountancy firm name	2019-12-31	CHERRY BEKAERT LLP
Accountancy firm EIN	2019-12-31	560574444
Accountancy firm EIN	2019-12-31	560574444
2018 : CANCER GENETICS, INC 401(K) P/S PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$419,895
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$803,839
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$768,191
Value of total corrective distributions	2018-12-31	$16,585
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$593,329
Value of total assets at end of year	2018-12-31	$2,978,064
Value of total assets at beginning of year	2018-12-31	$3,362,008
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$19,063
Total interest from all sources	2018-12-31	$2,483
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$71,253
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$71,253
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$250,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$586,203
Participant contributions at end of year	2018-12-31	$26,250
Participant contributions at beginning of year	2018-12-31	$61,716
Participant contributions at end of year	2018-12-31	$0
Participant contributions at beginning of year	2018-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$7,126
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-383,944
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$2,978,064
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$3,362,008
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$18,388
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$2,951,798
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$3,300,100
Interest on participant loans	2018-12-31	$2,482
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$16
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$192
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$192
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$1
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-247,170
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$0
Employer contributions (assets) at end of year	2018-12-31	$0
Employer contributions (assets) at beginning of year	2018-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$768,191
Contract administrator fees	2018-12-31	$675
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	LWBJ,LLP
Accountancy firm EIN	2018-12-31	421462849
2017 : CANCER GENETICS, INC 401(K) P/S PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$1,056,597
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$238,744
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$223,553
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$637,957
Value of total assets at end of year	2017-12-31	$3,362,008
Value of total assets at beginning of year	2017-12-31	$2,544,155
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$15,191
Total interest from all sources	2017-12-31	$2,465
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$59,692
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$59,692
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$250,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$611,861
Participant contributions at end of year	2017-12-31	$61,716
Participant contributions at beginning of year	2017-12-31	$68,553
Participant contributions at end of year	2017-12-31	$0
Participant contributions at beginning of year	2017-12-31	$37,362
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$26,096
Value of other receiveables (less allowance for doubtful accounts) at end of year	2017-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2017-12-31	$1,596
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$817,853
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$3,362,008
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$2,544,155
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$14,441
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$3,300,100
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$2,436,469
Interest on participant loans	2017-12-31	$2,464
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$192
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$175
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$175
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$1
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$356,483
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$0
Employer contributions (assets) at end of year	2017-12-31	$0
Employer contributions (assets) at beginning of year	2017-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$223,553
Contract administrator fees	2017-12-31	$750
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	LWBJ, LLP
Accountancy firm EIN	2017-12-31	421462849
2016 : CANCER GENETICS, INC 401(K) P/S PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$828,717
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$847,688
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$835,061
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$620,108
Value of total assets at end of year	2016-12-31	$2,544,155
Value of total assets at beginning of year	2016-12-31	$2,563,126
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$12,627
Total interest from all sources	2016-12-31	$4,091
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$0
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$250,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$603,710
Participant contributions at end of year	2016-12-31	$68,553
Participant contributions at beginning of year	2016-12-31	$90,273
Participant contributions at end of year	2016-12-31	$37,362
Participant contributions at beginning of year	2016-12-31	$43,567
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$16,398
Value of other receiveables (less allowance for doubtful accounts) at end of year	2016-12-31	$1,596
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2016-12-31	$1,935
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$-18,971
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$2,544,155
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$2,563,126
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Investment advisory and management fees	2016-12-31	$11,727
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$2,436,469
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$2,409,035
Interest on participant loans	2016-12-31	$4,091
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-12-31	$175
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-12-31	$18,316
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-12-31	$18,316
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$204,518
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$0
Employer contributions (assets) at end of year	2016-12-31	$0
Employer contributions (assets) at beginning of year	2016-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$835,061
Contract administrator fees	2016-12-31	$900
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	LWBJ, LLP
Accountancy firm EIN	2016-12-31	421462849
2015 : CANCER GENETICS, INC 401(K) P/S PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total transfer of assets to this plan	2015-12-31	$1,595,967
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$569,612
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$252,544
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$243,575
Value of total corrective distributions	2015-12-31	$2,548
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$597,362
Value of total assets at end of year	2015-12-31	$2,563,126
Value of total assets at beginning of year	2015-12-31	$650,091
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$6,421
Total interest from all sources	2015-12-31	$1,721
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$0
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$200,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$497,330
Participant contributions at end of year	2015-12-31	$90,273
Participant contributions at beginning of year	2015-12-31	$7,804
Participant contributions at end of year	2015-12-31	$43,567
Participant contributions at beginning of year	2015-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$100,032
Value of other receiveables (less allowance for doubtful accounts) at end of year	2015-12-31	$1,935
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2015-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$317,068
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$2,563,126
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$650,091
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$2,409,035
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$640,771
Interest on participant loans	2015-12-31	$1,718
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-12-31	$18,316
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$1,516
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$1,516
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-31	$3
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-29,471
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$0
Employer contributions (assets) at end of year	2015-12-31	$0
Employer contributions (assets) at beginning of year	2015-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$243,575
Contract administrator fees	2015-12-31	$6,421
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	LWBJ, LLP
Accountancy firm EIN	2015-12-31	421462849

Form 5500 Responses for CANCER GENETICS, INC 401(K) P/S PLAN

2020: CANCER GENETICS, INC 401(K) P/S PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	Yes
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: CANCER GENETICS, INC 401(K) P/S PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: CANCER GENETICS, INC 401(K) P/S PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: CANCER GENETICS, INC 401(K) P/S PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: CANCER GENETICS, INC 401(K) P/S PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: CANCER GENETICS, INC 401(K) P/S PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	CANCER GENETICS, INC
Employer identification number (EIN):	043462475
NAIC Classification:	541700